Clinical Trial Update: Ascorbic Acid (Vitamin C) Infusion in Human Sepsis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of ascorbic acid infusion in humans with sepsis/septic shock has been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension
• Lung Injury
• Sepsis
• Septic Shock

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Sepsis, Septic Shock | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-07-01